S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
Moscow says 50 Ukrainian drones shot down as attacks spark fires at Russian power stations
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
Moscow says 50 Ukrainian drones shot down as attacks spark fires at Russian power stations
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
Moscow says 50 Ukrainian drones shot down as attacks spark fires at Russian power stations
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
Moscow says 50 Ukrainian drones shot down as attacks spark fires at Russian power stations
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market

Heron Therapeutics (HRTX) Insider Trading & Ownership

$2.64
-0.07 (-2.58%)
(As of 04/19/2024 ET)

Heron Therapeutics (NASDAQ:HRTX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.40%
Number Of
Insiders Buying
(Last 12 Months)
4
Amount Of
Insider Buying
(Last 12 Months)
$3.67 M
Number Of
Insiders Selling
(Last 12 Months)
0
Get HRTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Heron Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

HRTX Insider Buying and Selling by Quarter

Heron Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/16/2023Craig A CollardCEOBuy150,000$0.92$138,000.00  
11/16/2023Ira DuarteCFOBuy85,000$0.89$75,650.00  
11/16/2023William P ForbesEVPBuy50,000$0.94$47,000.00  
7/21/2023Adam MorganDirectorBuy2,486,744$1.37$3,406,839.28  
(Data available from 1/1/2013 forward)

HRTX Insider Trading Activity - Frequently Asked Questions

Who is on Heron Therapeutics's Insider Roster?

The list of insiders at Heron Therapeutics includes Adam Morgan, Craig A Collard, Ira Duarte, Kimberly Manhard, Waage Christian, and William P Forbes. Learn more on insiders at HRTX.

What percentage of Heron Therapeutics stock is owned by insiders?

6.40% of Heron Therapeutics stock is owned by insiders. Learn more on HRTX's insider holdings.

Which Heron Therapeutics insiders have been buying company stock?

The following insiders have purchased HRTX shares in the last 24 months: Adam Morgan ($3,406,839.28), Craig A Collard ($138,000.00), Ira Duarte ($75,650.00), and William P Forbes ($47,000.00).

How much insider buying is happening at Heron Therapeutics?

Insiders have purchased a total of 2,771,744 HRTX shares in the last 24 months for a total of $3,667,489.28 bought.

Which Heron Therapeutics insiders have been selling company stock?

The following insider sold HRTX shares in the last 24 months: Kimberly Manhard ($7,159.04).

How much insider selling is happening at Heron Therapeutics?

Insiders have sold a total of 1,504 Heron Therapeutics shares in the last 24 months for a total of $7,159.04 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:HRTX) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners